Online citations, reference lists, and bibliographies.
← Back to Search

Superparamagnetic Iron Oxide Nanoparticles: Magnetic Nanoplatforms As Drug Carriers

Wahajuddin, Sumit Arora
Published 2012 · Materials Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
A targeted drug delivery system is the need of the hour. Guiding magnetic iron oxide nanoparticles with the help of an external magnetic field to its target is the principle behind the development of superparamagnetic iron oxide nanoparticles (SPIONs) as novel drug delivery vehicles. SPIONs are small synthetic γ-Fe2O3 (maghemite) or Fe3O4 (magnetite) particles with a core ranging between 10 nm and 100 nm in diameter. These magnetic particles are coated with certain biocompatible polymers, such as dextran or polyethylene glycol, which provide chemical handles for the conjugation of therapeutic agents and also improve their blood distribution profile. The current research on SPIONs is opening up wide horizons for their use as diagnostic agents in magnetic resonance imaging as well as for drug delivery vehicles. Delivery of anticancer drugs by coupling with functionalized SPIONs to their targeted site is one of the most pursued areas of research in the development of cancer treatment strategies. SPIONs have also demonstrated their efficiency as nonviral gene vectors that facilitate the introduction of plasmids into the nucleus at rates multifold those of routinely available standard technologies. SPION-induced hyperthermia has also been utilized for localized killing of cancerous cells. Despite their potential biomedical application, alteration in gene expression profiles, disturbance in iron homeostasis, oxidative stress, and altered cellular responses are some SPION-related toxicological aspects which require due consideration. This review provides a comprehensive understanding of SPIONs with regard to their method of preparation, their utility as drug delivery vehicles, and some concerns which need to be resolved before they can be moved from bench top to bedside.
This paper references
10.1016/S0927-7757(02)00305-9
Preparation and characterization of magnetite nanoparticles coated by amino silane
M. Ma (2003)
10.1016/j.jssc.2009.07.047
Magnetic Nanoparticles for Power Absorption: optimizing size, shape and magnetic properties.
M. González-Fernández (2009)
10.1016/j.nano.2011.08.017
Iron oxide nanoparticles for targeted cancer imaging and diagnostics.
Joshua E. Rosen (2012)
10.1016/J.JVIROMET.2007.08.028
Laboratory formulated magnetic nanoparticles for enhancement of viral gene expression in suspension cell line.
S. Bhattarai (2008)
10.1016/J.JCIS.2004.10.073
Sonochemical synthesis of stable hydrosol of Fe3O4 nanoparticles.
R. Abu Mukh-Qasem (2005)
10.4028/www.scientific.net/AMR.47-50.1097
Toxicology Studies of a Superparamagnetic Iron Oxide Nanoparticle In Vivo
S. Liu (2008)
10.1021/JA026501X
Size-controlled synthesis of magnetite nanoparticles.
S. Sun (2002)
10.3998/ARK.5550190.0008.508
Superparamagnetic iron oxide nanoparticles functionalized with peptides by electrostatic interactions
N. Hildebrandt (2006)
Synthesis and characterization of SiO2/(PMMA/Fe 3 O 4 ) magnetic nanocomposites
Z Wang (2008)
Tumoritropic and lymphotropic principles of macromolecular drugs.
H. Maeda (1989)
10.1021/la202951p
Colloidal gold modified with a genetically engineered nitroreductase: toward a novel enzyme delivery system for cancer prodrug therapy.
Vanessa V Gwenin (2011)
10.1016/J.JMMM.2008.05.048
Dual immobilization and magnetic manipulation of magnetic nanoparticles
S. Yang (2008)
10.1166/jnn.2008.033
Synthesis and characterization of SiO2/(PMMA/Fe3O4) magnetic nanocomposites.
Zhifei Wang (2008)
10.1002/NBM.924
Iron oxide MR contrast agents for molecular and cellular imaging
J. Bulte (2004)
10.1016/j.addr.2010.05.006
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
M. Mahmoudi (2011)
10.1097/01.rli.0000135980.08491.33
Macrophage Imaging in Central Nervous System and in Carotid Atherosclerotic Plaque Using Ultrasmall Superparamagnetic Iron Oxide in Magnetic Resonance Imaging
C. Corot (2004)
10.1002/mrm.10684
Noninvasive monitoring of stem cell transfer for muscle disorders
G. Walter (2004)
10.1016/J.JNONCRYSOL.2008.05.083
Magnetic and structural characterization of silver-iron oxide nanoparticles obtained by the microemulsion technique
E. Goikolea (2008)
10.1002/ADMA.200401545
One‐Pot Reaction to Synthesize Biocompatible Magnetite Nanoparticles
Zhen Li (2005)
10.1016/j.addr.2009.11.008
Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
B. Fadeel (2010)
10.1002/SMLL.200600009
Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery.
N. Kohler (2006)
10.2214/AJR.152.1.167
Superparamagnetic iron oxide: pharmacokinetics and toxicity.
R. Weissleder (1989)
10.2217/nnm.11.16
Superparamagnetic nanosystems based on iron oxide nanoparticles for biomedical imaging.
Fujun Liu (2011)
Nanovectors for anticancer agents based on superparamagnetic iron oxide nanoparticles
L. Douziech-Eyrolles (2007)
Synthesis and characterization of PVPcoated large core iron oxide nanoparticles as an MRI contrast agent
HY Lee (2008)
10.1002/ANIE.200602866
Magnetic nanoparticles: synthesis, protection, functionalization, and application.
A. Lu (2007)
10.1083/jcb.200910104
Targeting of drugs and nanoparticles to tumors
E. Ruoslahti (2010)
10.1016/j.ejpb.2008.07.008
Reduction in burst release of PLGA microparticles by incorporation into cubic phase-forming systems.
A. Ahmed (2008)
10.1016/j.ijpharm.2008.12.003
Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes.
L. Zhu (2009)
Locoregional cancer treatment with magnetic drug targeting.
C. Alexiou (2000)
10.1016/j.ejpb.2009.03.003
Dexamethasone-containing biodegradable superparamagnetic microparticles for intra-articular administration: physicochemical and magnetic properties, in vitro and in vivo drug release.
N. Butoescu (2009)
Wahajuddin and Arora International Journal of Nanomedicine
10.1002/ijc.23306
Magnetic resonance imaging‐based detection of glial brain tumors in mice after antiangiogenic treatment
A. Claes (2008)
10.1002/wnan.51
Monodisperse magnetic nanoparticles for biodetection, imaging, and drug delivery: a versatile and evolving technology.
S. Dave (2009)
10.1016/j.ijpharm.2008.08.020
Gelatin-coated magnetic iron oxide nanoparticles as carrier system: drug loading and in vitro drug release study.
B. Gaihre (2009)
10.1016/0021-9797(80)90187-3
Formation of uniform spherical magnetite particles by crystallization from ferrous hydroxide gels
T. Sugimoto (1980)
10.1007/978-1-4757-6482-6
Scientific and clinical applications of magnetic carriers
U. Häfeli (1997)
Engineered nanoparticles for biomolecular imaging. Nanoscale
M Mahmoudi (2011)
Poly (D, L-lactideco-glycolide) coated superparamagnetic iron oxide nanoparticles: synthesis, characterization and in vivo study as MRI contrast agent
D Patel (2008)
10.1016/j.biomaterials.2010.01.123
Hybrid superparamagnetic iron oxide nanoparticle-branched polyethylenimine magnetoplexes for gene transfection of vascular endothelial cells.
R. Namgung (2010)
10.1113/jphysiol.2007.139451
Cell tracking using magnetic resonance imaging
M. Hoehn (2007)
10.1016/j.nano.2009.04.002
Multifunctional magnetic nanoparticles for targeted delivery.
A. Kumar (2010)
10.1038/sj.bjc.6603707
Exploiting nanotechnology to target cancer
S. Sengupta (2007)
10.1109/TMAG.1981.1061188
Preparation of aqueous magnetic liquids in alkaline and acidic media
R. Massart (1981)
10.1039/B902394A
Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications
R. Qiao (2009)
Powered by TCPDF (www.tcpdf.org)
10.1002/jbm.a.33263
Magnetic field-induced acceleration of the accumulation of magnetic iron oxide nanoparticles by cultured brain astrocytes.
Marie-Christin Lamkowsky (2012)
10.2147/IJN.S13662
Pharmacokinetic parameters and tissue distribution of magnetic Fe3O4 nanoparticles in mice
J. Wang (2010)
10.1016/J.JCRYSGRO.2006.08.010
Sterically induced shape control of magnetite nanoparticles
L. Zhang (2006)
10.1021/JA01167A001
Theory, Production and Mechanism of Formation of Monodispersed Hydrosols
V. Lamer (1950)
10.1088/0022-3727/36/13/202
The preparation of magnetic nanoparticles for applications in biomedicine
P. Tartaj (2003)
10.1080/02656730802093679
Challenges in the development of magnetic particles for therapeutic applications
S. Barry (2008)
10.1002/CPHC.200300866
Probing nanomagnets' interactions inside colloidal superparamagnetic composites: aerosol versus surface template methods.
P. Tartaj (2003)
10.1109/TNB.2003.820277
Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies
A. Gupta (2004)
10.1016/J.JMMM.2004.11.155
Advances in magnetic nanoparticles for biotechnology applications
P. Tartaj (2005)
Synthesis and characterization of soluble iron oxidedendrimer composites
E Strable (2001)
10.1038/sj.jcbfm.9600241
Present Status of Magnetic Resonance Imaging and Spectroscopy in Animal Stroke Models
R. Weber (2006)
Colloid Surf. A-Physicochem. Eng. Asp.
T. Xia (2014)
10.1016/J.COLSURFA.2007.04.078
Poly(D,L-lactide-co-glycolide) coated superparamagnetic iron oxide nanoparticles : Synthesis, characterization and in vivo study as MRI contrast agent
D. Patel (2008)
10.1007/s11307-005-0008-1
Transfection of Neuroprogenitor Cells with Iron Nanoparticles for Magnetic Resonance Imaging Tracking: Cell Viability, Differentiation, and Intracellular Localization
S. Miyoshi (2005)
10.1016/j.biomaterials.2010.11.028
Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy.
Murali M Yallapu (2011)
10.1016/J.JMMM.2006.07.037
Preparation and magnetic properties of magnetite nanoparticles by sol-gel method
Hongzhang Qi (2010)
10.2147/ijn
科技期刊稿件处理的精细化管理——《International Journal of Nanomedicine〉〉投稿体会
鲁翠涛 (2014)
10.1038/74464
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells
M. Lewin (2000)
10.1016/S0304-8853(98)00551-4
Size characterization of magnetic cell sorting microbeads using flow field-flow fractionation and photon correlation spectroscopy
S. K. Williams (1999)
10.1002/NBM.970
A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging
A. Arbab (2005)
10.1148/RADIOL.2281020638
Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents.
J. Frank (2003)
10.1016/j.nano.2011.06.010
Magnetoliposomes with high USPIO entrapping efficiency, stability and magnetic properties.
A. Skouras (2011)
10.2147/IJN.S17574
Evaluation of iron oxide nanoparticle biocompatibility
A. Hanini (2011)
10.1016/0021-9797(91)90438-E
Analysis of the formation of monodisperse populations by homogeneous nucleation
C. D. Ouden (1991)
10.1088/0957-4484/20/13/135102
Magnetic chitosan nanoparticles as a drug delivery system for targeting photodynamic therapy.
Y. Sun (2009)
10.1007/s00441-004-0884-8
Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging
K. Briley-Saebø (2004)
10.1088/0957-4484/19/30/305102
Gold and magnetic oxide/gold core/shell nanoparticles as bio-functional nanoprobes.
I. S. Lim (2008)
10.1021/JP900798R
Superparamagnetic Iron Oxide Nanoparticles with Rigid Cross-linked Polyethylene Glycol Fumarate Coating for Application in Imaging and Drug Delivery
M. Mahmoudi (2009)
10.1111/j.1365-2990.2004.00557.x
Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours
E. Neuwelt (2004)
10.1021/cr2002596
Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles.
M. Mahmoudi (2012)
10.1016/J.BIOMATERIALS.2004.05.022
Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles.
A. Gupta (2005)
10.1021/bc700410z
Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling.
M. Babič (2008)
Molecular imaging. Radiology
R Weissleder (2001)
10.1161/01.STR.0000131268.50418.b7
In Vivo Detection of Macrophages in Human Carotid Atheroma: Temporal Dependence of Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced MRI
R. Trivedi (2004)
10.1021/LA0503451
Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells.
N. Kohler (2005)
10.1002/(SICI)1097-0215(19980209)75:4<626::AID-IJC22>3.0.CO;2-5
Magnetic resonance imaging of esophageal squamous cell carcinoma using magnetite particles coated with anti‐epidermal growth factor receptor antibody
Toshikazu Suwa (1998)
10.1016/J.JCIS.2007.03.023
Preparation of magnetite nanocrystals with surface reactive moieties by one-pot reaction.
F. Hu (2007)
10.1111/j.1528-1167.2008.01615.x
Functionalized magnetonanoparticles for MRI diagnosis and localization in epilepsy
Massoud Akhtari (2008)
10.1021/CM031104M
Starch-Coated Superparamagnetic Nanoparticles as MR Contrast Agents
D. Kim (2003)
10.1016/0304-8853(87)90047-3
Fractionation of a water-based ferrofluid☆
A. Nunes (1987)
CONTROLLING THE BURST EFFECT OF A DRUG BY INTRODUCING STARCH IN THE STRUCTURE OF MAGNETIC POLYURETHANE MICROSPHERES CONTAINING SUPER PARAMAGNETIC IRON OXIDE NANOPARTICLES
M. Mahmoudi (2010)
10.1016/j.phrs.2010.01.014
Magnetic nanoparticles and targeted drug delivering.
J. Chomoucka (2010)
10.1016/J.BIOMATERIALS.2004.07.023
Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells.
A. Petri-Fink (2005)
10.1016/J.MRI.2004.01.050
MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents.
M. Funovics (2004)
10.1002/mrm.10511
MR microscopy of magnetically labeled neurospheres transplanted into the Lewis EAE rat brain
J. Bulte (2003)
10.1016/S0168-1656(01)00427-8
DNA extraction using modified bacterial magnetic particles in the presence of amino silane compound.
B. Yoza (2002)
10.1002/ADEM.200990035
Cytotoxicity and Cell Cycle Effects of Bare and Poly(vinyl alcohol)‐Coated Iron Oxide Nanoparticles in Mouse Fibroblasts
M. Mahmoudi (2009)
10.1142/7938
Magnetic Nanoparticles
A. Feoktystov (2013)
10.1016/S0955-2219(98)00064-8
Hydroxyapatite precipitation: A case of nucleation-aggregation-agglomeration-growth mechanism
R. Rodríguez-Clemente (1998)
10.1016/S1567-2719(05)16005-3
chapter 5 Synthesis, Properties and Biomedical Applications of Magnetic Nanoparticles
P. Tartaj (2006)
Sonochemical synthesis and characterization of pure nanometer-sized Fe 3 O 4 particles
R Vijayakumar (2000)
Polyethyleniminebased non-viral gene delivery systems
U Lungwitz (2005)
10.1007/s002530051547
Bacterial magnetosomes: microbiology, biomineralization and biotechnological applications
D. Schüler (1999)
10.1016/J.JMMM.2005.01.083
Targeted drug delivery to magnetic implants for therapeutic applications
B. Yellen (2005)
In vivo imaging of proteolytic enzyme activity using a novel molecular reporter.
C. H. Tung (2000)
10.1021/nn200365a
The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo.
Xinglu Huang (2011)
10.1021/cn100100e
Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis.
M. Mahmoudi (2011)
10.1007/978-1-4612-5182-8_22
Magnetic microcapsules for targeted delivery of anticancer drugs.
T. Kato (1984)
10.3109/02656739309061478
Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia.
A. Jordan (1993)
10.1016/j.addr.2008.03.014
Multifunctional magnetic nanoparticles for targeted imaging and therapy.
J. Mccarthy (2008)
10.1016/j.addr.2009.03.007
Magnetic nanoparticles for theragnostics.
V. Shubayev (2009)
10.1016/J.ADDR.2006.09.013
Recent advances in iron oxide nanocrystal technology for medical imaging.
C. Corot (2006)
10.1016/J.JMMM.2006.10.776
One-pot polyol synthesis of monosize PVP-coated sub-5 nm Fe3O4 nanoparticles for biomedical applications
H. Liu (2007)
10.1021/CM970421O
Biomimetic Synthesis and Characterization of Magnetic Proteins (Magnetoferritin)
K. Wong (1998)
10.1016/J.JMMM.2005.01.080
Analysis of magnetic drug carrier particle capture by a magnetizable intravascular stent—2: Parametric study with multi-wire two-dimensional model
H. Chen (2005)
Formation and structural characterization
M De Cuyper (1988)
10.1023/A:1022030004597
Iron Particle Labeling of Haematopoietic Progenitor Cells: An In Vitro Study
Benoit Doche de Laquintane (2002)
10.1002/NBM.1007
Analysis of lesion development during acute inflammation and remission in a rat model of experimental autoimmune encephalomyelitis by visualization of macrophage infiltration, demyelination and blood‐brain barrier damage
C. Berger (2006)
10.1021/mp7001285
Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats.
Tapan Jain (2008)
10.3402/nano.v1i0.5358
Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)
N. Singh (2010)
10.3390/ijms12010012
Biological Properties of Iron Oxide Nanoparticles for Cellular and Molecular Magnetic Resonance Imaging
T. Schlorf (2010)
10.1186/1477-3155-4-4
The permeability of SPION over an artificial three-layer membrane is enhanced by external magnetic field
F. Mondalek (2006)
10.1124/jpet.106.101915
Interaction of Functionalized Superparamagnetic Iron Oxide Nanoparticles with Brain Structures
F. Cengelli (2006)
10.1021/nn2021088
Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles.
M. Mahmoudi (2011)
10.1246/CL.2008.530
A Novel Method to Synthesize Monodispersed Magnetite Nanoparticles
Feng Dang (2008)
10.1016/J.JMMM.2006.10.1132
Role of polyol in the synthesis of Fe particles
R. J. Joseyphus (2007)
Superparamagnetic iron oxide nanoparticles functionalized with peptides by electrostatic interactions. ARKIVOC
N Hildebrandt (2012)
10.1016/J.JMMM.2005.02.075
Intraarticular application of superparamagnetic nanoparticles and their uptake by synovial membrane—an experimental study in sheep
Katja Schulze (2005)
10.1007/s11095-012-0711-y
Magnetic Nanoparticles in Magnetic Resonance Imaging and Diagnostics
Christine Rümenapp (2012)
10.1016/S0304-8853(00)01239-7
Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia
A. Jordan (2001)
10.1021/MP060015P
Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy.
L. O. Cinteză (2006)
10.1016/j.expneurol.2004.02.007
In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord
I. Lee (2004)
10.1007/BF00256482
Magnetoliposomes. Formation and structural characterization.
M. de Cuyper (1988)
10.2174/187221009787003302
Strategies of large scale synthesis of monodisperse nanoparticles.
Hongtao Cui (2009)
10.1016/J.APSUSC.2010.04.110
Silane treatment of Fe3O4 and its effect on the magnetic and wear properties of Fe3O4/epoxy nanocomposites
J. Park (2010)
10.3109/02652049609026013
Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution.
C. Chouly (1996)
10.1016/J.JMMM.2009.02.038
Preparation of biodegradable magnetic microspheres with poly(lactic acid)-coated magnetite
H. Zhao (2009)
Chem Mater
(1998)
10.1039/B404844J
Biotechnological application of nano-scale engineered bacterial magnetic particles
T. Matsunaga (2004)
10.5772/22873
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
Xiang-hong Peng (2008)
10.1016/j.biomaterials.2008.12.017
Dexamethasone-containing PLGA superparamagnetic microparticles as carriers for the local treatment of arthritis.
N. Butoescu (2009)
10.1016/j.biomaterials.2010.11.040
Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting.
Adam J. Cole (2011)
Magnetism in medicine.
C. Breathnach (1983)
10.1016/S1076-6332(03)80212-X
Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI.
Eyk A Schellenberger (2002)
10.1021/BC049905I
Magneto/optical annexin V, a multimodal protein.
Eyk A Schellenberger (2004)
10.1016/j.jconrel.2009.10.002
Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.
P. Pradhan (2010)
In vivo detection of macrophages in human carotid atheroma. Stroke
RA Trivedi (2004)
MRI: Basic Principles and Applications
Y. Safriel (2003)
10.2147/IJN.S12162
The effect of magnetic nanoparticles of Fe3O4 on immune function in normal ICR mice
B. Chen (2010)
10.1016/j.colsurfb.2009.08.044
A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles.
M. Mahmoudi (2010)
10.1016/j.addr.2010.10.008
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
Sarbari Acharya (2011)
10.1002/AOC.155
Effect of the oxidation conditions on the maghemites produced by laser pyrolysis
S. Veintemillas-Verdaguer (2001)
10.1038/jcbfm.2009.192
Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review
J. Weinstein (2010)
10.1002/JBM.A.30781
Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI.
C. Sun (2006)
10.1126/SCIENCE.1636086
Magnetoferritin: in vitro synthesis of a novel magnetic protein.
F. Meldrum (1992)
10.1007/s00232-010-9271-4
Increased Cellular Uptake of Biocompatible Superparamagnetic Iron Oxide Nanoparticles into Malignant Cells by an External Magnetic Field
Sara Prijic (2010)
10.1158/0008-5472.CAN-06-1668
Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.
Chunfu Zhang (2007)
10.1166/JNN.2008.190
New biomimetic constructs for improved in vivo circulation of superparamagnetic nanoparticles.
A. Antonelli (2008)
10.1016/j.addr.2008.04.013
Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer.
M. Hamoudeh (2008)
10.1016/J.JCIS.2006.10.023
Facile synthesis of superparamagnetic magnetite nanoparticles in liquid polyols.
Wei Cai (2007)
Iron oxide nanoparticles for targeted cancer imaging and diagnostics. Nanomedicine
JE Rosen (2012)
10.1118/1.1636163
MRI: Basic Principles and Applications, 3rd edition
M. Brown (2004)
10.1002/DDR.20067
Magnetic nanoparticles for drug delivery
J. Dobson (2006)
10.1007/s11095-005-2496-8
Lyophilized Paclitaxel Magnetoliposomes as a Potential Drug Delivery System for Breast Carcinoma via Parenteral Administration: In Vitro and in Vivo Studies
J. Zhang (2005)
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Y. Matsumura (1986)
10.2147/IJN.S10458
Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells
X. Wu (2010)
10.1021/BC060186C
D-mannose-modified iron oxide nanoparticles for stem cell labeling.
D. Horák (2007)
10.1097/01.rli.0000197669.80475.dd
Preclinical Safety and Pharmacokinetic Profile of Ferumoxtran-10, an Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Contrast Agent
P. Bourrinet (2006)
10.1021/mp9001393
MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells.
J. S. Guthi (2010)
10.1016/0891-5849(95)02111-6
Iron-induced carcinogenesis: the role of redox regulation.
S. Toyokuni (1996)
10.1016/0021-9797(91)90347-B
Amino-silane modified superparamagnetic particles with surface-immobilized enzyme
H. Kobayashi (1991)
10.1016/J.JMMM.2005.01.064
Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system
T. Neuberger (2005)
10.1039/c1nr10326a
Engineered nanoparticles for biomolecular imaging.
M. Mahmoudi (2011)
Silane treatment of Fe 3 O 4 and its effect on the magnetic and wear properties of Fe 3 O 4 /epoxy nanocomposites
JO Park (2010)
10.1016/j.biomaterials.2010.08.039
Multifunctional SPIO/DOX-loaded wormlike polymer vesicles for cancer therapy and MR imaging.
Xiaoqiang Yang (2010)
10.1016/S0921-5093(00)00647-X
Sonochemical synthesis and characterization of pure nanometer-sized Fe3O4 particles
R. Vijayakumar (2000)
10.1021/CM070495S
Synthesis of Ultrasensitive Magnetic Resonance Contrast Agents for Cancer Imaging Using PEG-Fatty Acid
Jaemoon Yang (2007)
10.1088/0957-4484/21/39/395103
Degradability of superparamagnetic nanoparticles in a model of intracellular environment: follow-up of magnetic, structural and chemical properties.
M. Levy (2010)
10.1007/s11307-007-0130-3
Carboxylated Superparamagnetic Iron Oxide Particles Label Cells Intracellularly Without Transfection Agents
V. Mailänder (2007)
10.1002/(SICI)1522-2586(199902)9:2<228::AID-JMRI12>3.0.CO;2-K
Improved delineation of human brain tumors on MR images using a long‐circulating, superparamagnetic iron oxide agent
W. S. Enochs (1999)
10.1016/J.COPBIO.2006.11.001
Emerging concepts in molecular MRI.
D. Sosnovik (2007)
10.1039/b700091j
Ultrasensitive detection and molecular imaging with magnetic nanoparticles.
J. Yang (2008)
10.1006/JCIS.1997.4889
Size Modulation of Polymeric Nanoparticles under Controlled Dynamics of Microemulsion Droplets
Munshi (1997)
10.1016/J.JMMM.2006.10.1194
Characterization of PEI-coated superparamagnetic iron oxide nanoparticles for transfection: Size distribution, colloidal properties and DNA interaction
B. Steitz (2007)
10.1016/J.JMMM.2004.11.093
Synthesis of ferrofluid with magnetic nanoparticles by sonochemical method for MRI contrast agent
E. Kim (2005)
10.1016/J.JMMM.2006.10.1195
Development of magnetically targeted drug delivery system using superconducting magnet
S. Takeda (2007)
10.1021/CM010125I
Synthesis and Characterization of Soluble Iron Oxide−Dendrimer Composites
E. Strable (2001)
10.1016/j.addr.2009.11.002
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.
O. Veiseh (2010)
10.1007/S12039-008-0081-5
Role of carboxylate ion and metal oxidation state on the morphology and magnetic properties of nanostructured metal carboxylates and their decomposition products
A. Ganguly (2008)
10.1016/j.biomaterials.2011.07.026
Dendronized iron oxide nanoparticles for multimodal imaging.
G. Lamanna (2011)
10.1016/J.IJPHARM.2006.12.002
Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles.
A. Cirstoiu-Hapca (2007)
10.1016/j.bmc.2007.12.051
Synthesis of chemically functionalized superparamagnetic nanoparticles as delivery vectors for chemotherapeutic drugs.
S. Hanessian (2008)
10.1371/journal.pmed.0010066
Sensitive, Noninvasive Detection of Lymph Node Metastases
M. Harisinghani (2004)
10.1016/j.jconrel.2011.01.024
Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro.
Forrest M Kievit (2011)
10.1016/S1369-7021(11)70163-8
Magnetite Nanoparticles for Medical MR Imaging.
Zachary Stephen (2011)
10.1007/s11427-011-4215-5
The internalization pathway, metabolic fate and biological effect of superparamagnetic iron oxide nanoparticles in the macrophage-like RAW264.7 cell
Jingli Gu (2011)
10.1038/nbt1201-1141
Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells
J. Bulte (2001)
10.1016/J.JMMM.2005.01.087
Magnetizable implants and functionalized magnetic carriers: A novel approach for noninvasive yet targeted drug delivery
A. Rosengart (2005)
10.1016/J.RCL.2005.05.004
Contrast agents for MR imaging of the liver.
N. C. Balcı (2005)
logical properties of iron oxide nanoparticles for cellular and molecular magnetic resonance imaging
AS Arbab (2011)
Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent. Nanotechnology
HY Lee (2008)
10.1016/S1076-6332(03)80210-6
Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents.
P. Wunderbaldinger (2002)
10.1038/nrd1033
Effect of pegylation on pharmaceuticals
J. Harris (2003)
10.1016/j.addr.2009.11.006
Targeted hyperthermia using metal nanoparticles.
P. Cherukuri (2010)
10.1016/j.nano.2008.05.004
Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo.
Chengli Yang (2008)
10.1002/mrm.20701
Instant MR labeling of stem cells using magnetoelectroporation
P. Walczak (2005)
International Journal of Nanomedicine downloaded from
Arora Wahajuddin
10.1016/S0730-725X(96)00335-9
Crystal size and properties of superparamagnetic iron oxide (SPIO) particles.
C. Sjögren (1997)
10.1016/j.jconrel.2010.08.027
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
F. Danhier (2010)
10.1097/WCO.0b013e328337f4b5
New approaches to neuroimaging of central nervous system inflammation
G. Stoll (2010)
10.1002/ADMA.200600385
Preparation of biocompatible magnetite nanocrystals for in vivo magnetic resonance detection of cancer
F. Hu (2006)
10.1007/978-1-60761-901-7
Molecular Imaging
K. Luker (2011)
10.1016/j.biomaterials.2011.02.031
Long term in vivo biotransformation of iron oxide nanoparticles.
M. Levy (2011)
10.1016/j.jcis.2009.04.046
Cell toxicity of superparamagnetic iron oxide nanoparticles.
M. Mahmoudi (2009)
10.1016/j.biomaterials.2010.01.057
Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy.
F. Dilnawaz (2010)
10.1016/J.MATLET.2005.04.013
Preparation and characterization of magnetic PLA–PEG composite particles
J. Ren (2005)
10.1002/jmri.20057
Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: Clinical implications for ultrasmall superparamagnetic iron oxide‐enhanced magnetic resonance imaging
M. Rausch (2004)
10.1002/NBM.1011
Lipid‐based nanoparticles for contrast‐enhanced MRI and molecular imaging
W. Mulder (2006)
10.1371/journal.pone.0025524
Mechanism of Cellular Uptake and Impact of Ferucarbotran on Macrophage Physiology
Chung-Yi Yang (2011)
10.1002/smll.200801328
Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging.
E. Amstad (2009)
10.1016/J.JMMM.2008.11.022
Magnetic nanoparticles: Internal probes and heaters within living cells
C. Wilhelm (2009)
Formation and structural characterization
M DeCuyper (1988)
Multifunctional SPIO/DOXloaded wormlike polymer vesicles for cancer therapy and MR imaging
X Yang (2010)
10.1021/CM980742F
Electrochemical Synthesis for the Control of γ-Fe2O3 Nanoparticle Size. Morphology, Microstructure, and Magnetic Behavior
Cécile Pascal (1999)
10.1016/j.addr.2008.03.018
Magnetic nanoparticles in MR imaging and drug delivery.
C. Sun (2008)
10.2217/17435889.2.2.153
Targeted delivery of multifunctional magnetic nanoparticles.
J. Mccarthy (2007)
10.1016/j.ijpharm.2011.10.019
Heparin-coated superparamagnetic nanoparticle-mediated adeno-associated virus delivery for enhancing cellular transduction.
Jun-ho Hwang (2011)
10.1002/MRM.1910290108
Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran‐magnetite particles
J. Bulte (1993)
10.1021/JP808425K
Bifunctional Nanoparticles with Magnetization and Luminescence
L. Wang (2009)
10.1002/mrm.10585
Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles
P. Jendelová (2003)
10.1088/0957-4484/19/16/165101
Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent.
Ha-young Lee (2008)
10.1126/science.1125949
Molecular Imaging in Cancer
R. Weissleder (2006)



This paper is referenced by
10.1016/J.MATDES.2016.09.031
Synthesis and characterization of manganese ferrite nanoparticles obtained by electrochemical/chemical method
E. Mazarío (2016)
10.1155/2013/680712
Use of Magnetic Folate-Dextran-Retinoic Acid Micelles for Dual Targeting of Doxorubicin in Breast Cancer
J. Varshosaz (2013)
10.1016/J.ECOLENG.2016.03.012
Enhancement of heavy metals sorption via nanocomposites of rice straw and Fe3O4 nanoparticles using artificial neural network (ANN)
Roshanak Khandanlou (2016)
10.1016/J.MATCHEMPHYS.2015.01.002
Synthesis of porous superparamagnetic iron oxides from colloidal nanoparticles: Effect of calcination temperature and atmosphere
W. Cheng (2015)
10.1016/j.msec.2019.110104
Magnetic, fluorescent and hybrid nanoparticles: From synthesis to application in biosystems.
Gonçalo A. Marcelo (2020)
10.5101/NBE.V8I4.P246-267
Metal, Metalloid, and Oxide Nanoparticles for Therapeutic and Diagnostic Oncology
Mohammad Hossein Yazdi (2016)
10.1088/2043-6254/AA5E33
New developments in breast cancer therapy: role of iron oxide nanoparticles
Shivani Thoidingjam (2017)
10.19080/OAJS.2017.03.555621
The Next Giant Leap in Spinal Surgery: Is it Nanotechnology?
Vibhu Krishnan Viswanathan (2017)
Stabilization study of surface modified magnetite nanoparticles in nitrile butadiene rubber latex / Tai Mun Foong
Mun Foong Tai (2016)
10.3390/ijms21103476
Improving the Size Homogeneity of Multicore Superparamagnetic Iron Oxide Nanoparticles
Barry J Yeh (2020)
10.1371/journal.pone.0115636
Tumor Cell Targeting by Iron Oxide Nanoparticles Is Dominated by Different Factors In Vitro versus In Vivo
C. Ndong (2015)
10.1016/J.OPTMAT.2019.03.031
Optical evidence of magnetic field-induced ferrofluid aggregation: Comparison of cobalt ferrite, magnetite, and magnesium ferrite
Mladen Lakić (2019)
10.1007/s13726-015-0370-z
Carboxymethyl starch-coated iron oxide magnetic nanoparticles: a potential drug delivery system for isoniazid
Chinmayee Saikia (2015)
10.1016/J.JALLCOM.2018.02.206
Controlled shell on nanoparticles as a tool to regulate the properties of immobilized molecules
J. Gu (2018)
10.1016/J.MATCHEMPHYS.2015.05.018
Hydrothermal synthesis of nanostructured hybrids based on iron oxide and branched PEI polymers. Influence of high pressure on structure and morphology
L. M. Popescu (2015)
10.1016/J.BCAB.2019.101296
Spiny amaranth leaf extract mediated iron oxide nanoparticles: Biocidal photocatalytic propensity, stability, dissolubility and reusability
M. Harshiny (2019)
10.1039/c9cc03969d
Tunable functionalization of silica coated iron oxide nanoparticles achieved through a silanol-alcohol condensation reaction.
Henry J H Kang (2019)
10.3390/nano8100776
PEGylation of Superparamagnetic Iron Oxide Nanoparticles with Self-Organizing Polyacrylate-PEG Brushes for Contrast Enhancement in MRI Diagnosis
E. Illés (2018)
10.1007/S12668-019-00614-2
Binding Parameters of Magnetite Nanoparticles Interaction with Anticancer Drug Doxorubicin
E. Bereznyak (2019)
10.1016/J.JALLCOM.2018.09.125
Fabrication of magnetic phase change n-eicosane @ Fe3O4/SiO2 microcapsules on wood surface via sol-gel method
Temeng Qian (2019)
10.1016/j.clim.2015.02.003
Nanoparticle-based autoimmune disease therapy.
P. Serra (2015)
10.1007/978-1-4614-8993-1_12
Cytotoxicity and Genotoxicity of Iron Oxides Nanoparticles
A. B. Seabra (2014)
Application of Glycoconjugate-Functionalized Magnetic Nanoparticles as Potent Anti-Adhesion and Anti-Bacterial Agents
Y. Raval (2017)
10.1080/10717544.2019.1587047
Recent progress in LyP-1-based strategies for targeted imaging and therapy
Ningning Song (2019)
10.1016/j.ijbiomac.2018.08.118
Methotrexate loaded on magnetite iron nanoparticles coated with chitosan: Biosynthesis, characterization, and impact on human breast cancer MCF-7 cell line.
E. M. Ali (2018)
10.3390/nano10040757
Influence of Experimental Parameters of a Continuous Flow Process on the Properties of Very Small Iron Oxide Nanoparticles (VSION) Designed for T1-Weighted Magnetic Resonance Imaging (MRI)
T. Vangijzegem (2020)
10.1039/C9TB00029A
Enhanced hyperthermic properties of biocompatible zinc ferrite nanoparticles with a charged polysaccharide coating
D. Lachowicz (2019)
10.1016/J.ARABJC.2018.04.013
Green biosynthesis of superparamagnetic magnetite Fe3O4 nanoparticles and biomedical applications in targeted anticancer drug delivery system: A review
Yen Pin Yew (2020)
10.34171/mjiri.33.16
In-vitro prostate cancer biomarker detection by directed conjugation of anti-PSCA antibody to super paramagnetic iron oxide nanoparticless
Mahboube Shahrabi Farahani (2019)
Hybrid Metallic Nanostructures for Bio and Analytical Applications
Nafiseh Moghimi (2015)
10.1007/s10973-016-5393-y
Investigation of magnetite nanoparticles stability in air by thermal analysis and FTIR spectroscopy
M. Stoia (2016)
10.1007/s13204-018-0798-5
Cyclodextrin–PEG conjugate-wrapped magnetic ferrite nanoparticles for enhanced drug loading and release
Israel V. M. V. Enoch (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar